Register entry
- Registered sites
- 0
- Active NDC listings
- 30
- Labeller names
- 2
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
3030 active NDC listings: 30 human prescription drug. By marketing category: ANDA 25, UNAPPROVED DRUG OTHER 5.
| Dosage form | NDCs |
|---|---|
| capsule, extended release | 14 |
| tablet | 7 |
| tablet, extended release | 4 |
| injection, solution | 3 |
| capsule | 1 |
| solution | 1 |
| Route | NDCs |
|---|---|
| oral | 27 |
| intramuscular | 3 |
| Labeller name on the listing | NDCs |
|---|---|
| vitruvias therapeutics | 16 |
| vitruvias therapeutics, inc. | 14 |
Catalogue
Marketed products
30| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Aminocaproic Acid | Aminocaproic Acid | solution, oral | 69680-114ANDA |
| Aminocaproic Acid | Aminocaproic Acid | tablet, oral | 69680-115ANDA |
| Aminocaproic Acid | Aminocaproic Acid | tablet, oral | 69680-116ANDA |
| Bupropion hydrochloride (XL) | Bupropion hydrochloride | tablet, extended release, oral | 69680-157ANDA |
| Bupropion hydrochloride (XL) | Bupropion hydrochloride | tablet, extended release, oral | 69680-158ANDA |
| Cyanocobalamin | Cyanocobalamin | injection, solution, intramuscular | 69680-112ANDA |
| Cyanocobalamin | Cyanocobalamin | injection, solution, intramuscular | 69680-113ANDA |
| Cyanocobalamin | Cyanocobalamin | injection, solution, intramuscular | 69680-121ANDA |
| Icosapent Ethyl | Icosapent Ethyl | capsule, oral | 69680-186ANDA |
| Memantine Hydrochloride | memantine hydrochloride | capsule, extended release, oral | 69680-161ANDA |
| Memantine Hydrochloride | memantine hydrochloride | capsule, extended release, oral | 69680-162ANDA |
| Memantine Hydrochloride | memantine hydrochloride | capsule, extended release, oral | 69680-163ANDA |
| Memantine Hydrochloride | memantine hydrochloride | capsule, extended release, oral | 69680-164ANDA |
| Pramipexole Dihydrochloride | Pramipexole Dihydrochloride | tablet, extended release, oral | 69680-146ANDA |
| Pramipexole Dihydrochloride Extended-Release | Pramipexole Dihydrochloride | tablet, extended release, oral | 69680-145ANDA |
| Propafenone Hydrochloride | propafenone | capsule, extended release, oral | 69680-130ANDA |
| Propafenone Hydrochloride | propafenone | capsule, extended release, oral | 69680-131ANDA |
| Propafenone Hydrochloride | propafenone | capsule, extended release, oral | 69680-132ANDA |
| Thyroid | THYROID | tablet, oral | 69680-165UNAPPROVED DRUG OTHER |
| Thyroid | THYROID | tablet, oral | 69680-166UNAPPROVED DRUG OTHER |
| Thyroid | THYROID | tablet, oral | 69680-167UNAPPROVED DRUG OTHER |
| Thyroid | THYROID | tablet, oral | 69680-168UNAPPROVED DRUG OTHER |
| Thyroid | THYROID | tablet, oral | 69680-169UNAPPROVED DRUG OTHER |
| Topiramate | Topiramate | capsule, extended release, oral | 69680-177ANDA |
| Topiramate | Topiramate | capsule, extended release, oral | 69680-178ANDA |
| Topiramate | Topiramate | capsule, extended release, oral | 69680-179ANDA |
| Topiramate | Topiramate | capsule, extended release, oral | 69680-180ANDA |
| Topiramate | Topiramate | capsule, extended release, oral | 69680-181ANDA |
| memantine hydrochloride and donepezil hydrochloride | memantine hydrochloride and donepezil hydrochloride | capsule, extended release, oral | 69680-183ANDA |
| memantine hydrochloride and donepezil hydrochloride | memantine hydrochloride and donepezil hydrochloride | capsule, extended release, oral | 69680-185ANDA |
Compare
Other companies listing thyroid
- Oliva Therapeutics, LLC0 sites · 11 NDC
Enquiry
Common questions
- Is Vitruvias Therapeutics, Inc. FDA approved?
- Vitruvias Therapeutics, Inc. holds no registered establishment of its own; 30 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Vitruvias Therapeutics, Inc. make?
- 30 products are listed under Vitruvias Therapeutics, Inc. in the openFDA NDC Directory, most often as capsule, extended release; tablet; tablet, extended release. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.